INTERVENTIONAL AND STRUCTURAL CARDIOLOGIST BROADENS HOBART’S SURGICAL ABILITIES Tasmanian born, bred and educated cardiologist
With
Dr Heath Adams,
Interventional and Structural Cardiologist
Director of Structural Intervention, Royal Hobart Hospital &
Visiting Medical Officer (VMO) Cardiologist
Hobart Private Hospital &
Adjunct Senior Researcher
Menzies Institute for Medical Research,
University of Tasmania
PEOPLE IN HEATH CARE | AUSTRALIAN HEATH JOURNAL SEGMENT
Filmed in Hobart | March 2025
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
Dr Adams achieved First Class Honours in MBBS at UTAS in 2009. He achieved a Fellowship of the Royal College of Physicians in Adult Cardiology in 2016 after training appointments in Victoria. In 2019, he was the structural heart fellow at St Thomas’ Hospital, London, a worldwide centre of excellence in TAVI and structural heart procedures. This fellowship was supported by the prestigious Dr MG Ciezar Memorial Scholarship in cardiovascular medicine from the University of Tasmania.
Dr Adams has published over 50 manuscripts and abstracts in peer-reviewed journals and has been involved in authoring educational book chapters on TAVI. His current research involves streamlined TAVI, assessing frailty outcomes post valve intervention and performing large-scale real-world outcomes with new structural heart interventions. Dr Adams is a clinical supervisor for trainee physicians at the Royal Hobart Hospital, is a member of the CSANZ Interventional Council.
Heath is passionate about clinical innovation, research and patient outcomes. In his free time, Heath enjoys bushwalking, running, cycling and trying to better his golf game whilst being a busy father to 3 children under the age of 6.
Source: supplied and supplemented
-
Imperatives for women diagnosed with ovarian cancer
Professor Clare Scott, a pioneering clinician scientist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, also serves as a medical oncologist at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
Her comprehensive training in medical oncology has fuelled her specialisation in gynaecological cancer, combining rigorous research with clinical trials to improve patient outcomes. With over a decade of involvement in ANZGOG, Australia’s foremost gynaecologic cancer research organisation, she is deeply committed to advancing research and saving lives.
-
Pharmacist Prescribing Model gets further support from state health
A full scope pharmacist prescriber model allows pharmacists to independently prescribe medicines within their professional competence, without requiring prior doctor authorisation. It extends pharmacists’ role beyond dispensing to include assessment, diagnosis of minor and chronic conditions, initiation and modification of therapy, and ongoing patient monitoring. This model integrates pharmacists into primary care teams, aiming to improve timely access to treatment, reduce pressure on general practitioners, and enhance continuity of care. Pharmacists use their clinical knowledge, patient records, and collaborative pathways to ensure safe prescribing. The model emphasises training, regulation, and accountability to maintain high standards of patient safety.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
